A grading system of dynamic fibrinolysis resistance in sepsis associates with ICU outcomes

This prospective observational study of 116 sepsis patients demonstrates that a new point-of-care grading system for dynamic fibrinolysis resistance, derived from viscoelastic testing, effectively stratifies mortality risk and tracks clinical outcomes, where higher grades correlate with increased severity and death, while improvement in grade predicts favorable recovery.

The Gist

The Big Picture: The Body's "Cleanup Crew" is Stuck

Imagine your body is a busy city. When you get a severe infection (sepsis), it's like a massive riot breaks out. To stop the riot, your body's defense system builds a lot of "barriers" (blood clots) to trap the bad bacteria.

Normally, once the riot is contained, a specialized cleanup crew (called fibrinolysis) comes in to dissolve those barriers and clear the streets so traffic (blood flow) can move freely again.

The Problem: In severe sepsis, this cleanup crew often gets overwhelmed or blocked. They can't dissolve the barriers fast enough. The streets get clogged, traffic stops, and the city's buildings (your organs) start to shut down because they aren't getting supplies. This is called fibrinolysis resistance.

What Did the Researchers Do?

The researchers wanted to create a simple "traffic report" for doctors. Currently, measuring how stuck the cleanup crew is is complicated and hard to interpret. They wanted a simple grading system (like a weather forecast) that tells a doctor immediately: "Is the cleanup crew working fine, slightly slow, or completely stuck?"

They studied 116 patients in the ICU with sepsis. They used a special point-of-care machine (like a high-tech blood test) that simulates a clot forming and then tries to break it down.

The "Traffic Light" Grading System

By analyzing the data, they found that patients naturally fell into three distinct groups, which they called Grades 1, 2, and 3. Think of this like a traffic light system for the body's ability to clear clots:

• 🟢 Grade 1 (Green Light - Normal): The cleanup crew is working perfectly. Even though there are lots of clots (due to the infection), the body is dissolving them at the right speed. These patients generally did well.
• 🟡 Grade 2 (Yellow Light - Warning): The cleanup crew is struggling. They are slower than normal, but they are still moving. This is a warning sign that the situation is getting serious, but it's not a disaster yet.
• 🔴 Grade 3 (Red Light - Danger): The cleanup crew is completely stuck. The barriers aren't dissolving at all. The streets are totally clogged. This is the danger zone. Patients in this group had the highest risk of organ failure and death.

Key Findings: It's Not Just a Snapshot; It's a Movie

The most exciting part of this study is that they didn't just take one picture; they watched the "movie" over the first week of ICU stay.

1. The "Red Light" is Deadly: Patients who started in Grade 3 (Red Light) had a much higher chance of dying (about 42%) compared to those in Grade 1 (15%).
2. Movement Matters: The system isn't static. Patients often moved between grades.
   • If a patient started in Grade 3 (Red) and their body managed to improve to Grade 2 or 1 (Yellow/Green) within a week, their chances of survival went up significantly.
   • If they stayed in Grade 3 or got worse, the outlook was very poor.
3. Why is it stuck? The researchers looked at the blood chemistry and found why the crew was stuck. In Grade 3 patients, there was too much "brake fluid" (inhibitors like PAI-1) and not enough "workers" (plasminogen). The body was actively preventing the cleanup crew from working.

The "Fix-It" Experiment

To prove their theory, the researchers did a little experiment in the lab. They took blood from patients who were stuck in the "Red Light" (Grade 3) and tried to fix it manually:

• Adding more "dissolver" (tPA): This helped a little bit, but not enough.
• Removing the "brakes" (blocking inhibitors): This worked much better! When they blocked the inhibitors, most of the stuck blood started flowing again.

This suggests that for the sickest patients, treatments that specifically target these "brakes" might save lives.

The Takeaway for You

This paper introduces a new simple tool for doctors. Instead of getting lost in complex numbers, a doctor can now look at a patient's blood test and say:

• "Your cleanup crew is working fine." (Grade 1)
• "They are slowing down; we need to watch closely." (Grade 2)
• "They are completely stuck; this patient is in critical danger and needs aggressive help." (Grade 3)

Most importantly, it shows that if you can get the cleanup crew moving again, the patient has a much better chance of surviving. It turns a confusing biological process into a clear, actionable signal for saving lives.

Technical Summary

1. Problem Statement

Sepsis induces a dysregulated host response leading to widespread microthrombi and organ failure. A critical component of this pathology is fibrinolysis resistance (impaired clot breakdown), which allows thrombi to persist and extend, contributing to tissue hypoperfusion and death.

• Current Gap: While impaired fibrinolysis is recognized in sepsis, its severity is often viewed as a binary state (present/absent) or measured at a single time point. The degree (severity) and dynamics (how it changes over time) of fibrinolysis resistance in acute sepsis remain poorly defined.
• Clinical Need: There is a lack of a simple, point-of-care tool to grade the severity of fibrinolysis resistance, correlate it with disease acuity, and guide therapeutic interventions before irreversible organ damage occurs.

2. Methodology

Study Design:

• Type: Prospective observational cohort study.
• Setting: Intensive Care Unit (ICU) at Liverpool Hospital, Australia.
• Population: 116 adult patients with sepsis or septic shock (Sepsis-3 criteria).
• Controls: 26 healthy volunteers and 32 non-septic cardiac surgery patients.
• Exclusions: Pre-existing chronic coagulation disorders, pregnancy, palliative intent, or first measurement >72 hours post-admission.

Data Collection & Measurements:

• Viscoelastic Testing (VET): Used the ClotPro® system with tissue plasminogen activator (tPA)-enhanced testing (tPA-VET).
  • Assay: TPA-test (EX-test + 650 ng/mL tPA).
  • Key Metric: The study introduced a novel, fibrin-adjusted ratio: TPA-LT/FIBA10 (Clot Lysis Time in seconds divided by Fibrin Clot Amplitude at 10 minutes in mm). This adjustment accounts for the fact that higher fibrinogen levels (common in sepsis) naturally prolong lysis time.
• Frequency: Sequential measurements were taken (median 3 per patient) over the first week of ICU admission.
• Biomarkers: A nested substudy (40 patients, 162 samples) measured plasma levels of fibrinolysis proteins (PAI-1, plasminogen, tPA activity, $\alpha_2$-antiplasmin, PAP complex) via ELISA.
• Ex Vivo Reversibility: A subset of samples was tested by adding alteplase (doubling tPA), plasminogen, or an $\alpha_2$-antiplasmin inhibitory antibody to determine the mechanistic cause of resistance.

Statistical Analysis:

• Cluster Analysis: Gaussian Mixture Model (Box-Cox transformed) was used to identify distinct clusters of fibrinolysis resistance.
• Outcomes: Correlated with APACHE III, SOFA, SIC, and DIC scores, as well as 28-day mortality.
• Modeling: Used Aalen-Johansen multistate models for competing risks and multi-state Markov models to analyze transitions between grades.

3. Key Contributions

1. Development of a Grading System: Established a data-driven, three-tiered grading system (Grades 1–3) for fibrinolysis resistance based on the TPA-LT/FIBA10 ratio.
2. Dynamic Monitoring: Demonstrated that fibrinolysis resistance is not static; patients frequently transition between grades during the first week of ICU admission.
3. Mechanistic Validation: Linked the clinical grades to specific plasma protein profiles (e.g., high PAI-1, low plasminogen) and validated the reversibility of resistance via ex vivo manipulation.
4. Clinical Utility: Created a simple, bedside-calculable metric that aligns with established severity scores and predicts mortality risk.

4. Key Results

The Grading System (TPA-LT/FIBA10):

• Grade 1 (<13 sec/mm): Represents preserved fibrinolysis. Includes all healthy controls and non-septic patients. Correlates linearly with fibrin clot amplitude.
• Grade 2 (13 to <26 sec/mm): Moderate resistance.
• Grade 3 (≥26 sec/mm): Severe resistance. Associated with a loss of linear correlation between lysis time and clot amplitude.

Clinical Associations:

• Severity: Grade 3 on admission correlated with the highest APACHE III, SOFA, SIC, and DIC scores, and the highest requirement for vasopressors, dialysis, and mechanical ventilation.
• Mortality:
  • Grade 3: 42% mortality at 28 days. Hazard Ratio (HR) for death was 3.92 (95% CI 1.35–11.4) compared to Grade 1.
  • Grade 2: 24% mortality (no significant difference from Grade 1).
  • Grade 1: 15% mortality.
• Dynamics: Transitions between grades were frequent. Patients who transitioned from a higher grade (e.g., Grade 3) to a lower grade (e.g., Grade 1 or 2) within the first 7 days had significantly improved survival probabilities. Conversely, persistent Grade 3 resistance was strongly predictive of death.

Biomarker & Mechanistic Findings:

• Grade 3 Profile: Characterized by elevated PAI-1 activity, reduced plasminogen, and high PAI-1/tPA and $\alpha_2$-antiplasmin/plasminogen ratios.
• Reversibility (Ex Vivo):
  • Grade 2: Fully reversible to Grade 1 by doubling tPA concentration or adding an $\alpha_2$-antiplasmin inhibitor.
  • Grade 3: Less responsive to tPA alone (only 26% reverted to Grade 1). However, adding plasminogen or an $\alpha_2$-antiplasmin inhibitor successfully reduced 77–89% of Grade 3 cases to Grade 1. This suggests Grade 3 resistance is driven by a combination of high inhibitors and substrate (plasminogen) depletion.

5. Significance and Conclusion

• Prognostic Value: This grading system provides a rapid, point-of-care method to stratify sepsis patients by mortality risk, outperforming static single-time measurements.
• Therapeutic Guidance: The dynamic nature of the grades suggests that monitoring fibrinolysis can serve as a real-time indicator of patient trajectory. Improvement in grade correlates with survival.
• Precision Medicine: The mechanistic data (ex vivo reversibility) suggests that different grades of resistance may require different therapeutic strategies (e.g., Grade 3 may require plasminogen replacement or $\alpha_2$-antiplasmin inhibition rather than just increasing tPA).
• Future Impact: This tool could enrich clinical trials for sepsis by identifying specific "fibrinolysis-resistant" phenotypes, potentially breaking the stagnation in developing effective antithrombotic therapies for sepsis.

Limitations: The study was single-center and observational. Some DIC scores required data imputation due to missing routine lab data. The grading system requires validation in larger, multi-center cohorts.